Photobiomodulation therapy for treatment olfactory and taste dysfunction COVID-19-related: A case report.
J Biophotonics
; 15(8): e202200058, 2022 08.
Article
in English
| MEDLINE | ID: covidwho-1802312
ABSTRACT
It is postulated that the inflammatory process resulting from SARS-CoV-2 infection is the main cause of smell and taste dysfunctions in patients. In view of this, photobiomodulation, due to its anti-inflammatory and antioxidant effects, may be a promising therapeutic modality to treat these disorders. In the present case report, we observed clinical improvement in the symptoms of anosmia and ageusia related to COVID-19 after treatment with photobiomodulation. Due to the inflammatory nature of COVID-19 and the anti-inflammatory effects, photobiomodulation antioxidants already proven in the literature make it a promising therapeutic modality, especially sequela COVID-related, including olfactory (anosmia) and taste (ageusia) dysfunction. In the present case report, the patient's olfactory and gustatory functions were re-established after 10 treatment sessions with photobiomodulation.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Low-Level Light Therapy
/
Ageusia
/
COVID-19
/
Olfaction Disorders
Type of study:
Case report
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
J Biophotonics
Journal subject:
Biophysics
Year:
2022
Document Type:
Article
Affiliation country:
Jbio.202200058
Similar
MEDLINE
...
LILACS
LIS